A Clinical Study Know the efficacy of Ayurveda Medicines in COVID 19 Positive Patients

An open label controlled clinical study to evaluate the efficacy of Ayurveda Medicines - Sudarshana churna, Yestimadhu churna and Amrtharista as add on therapy on Symptomatology, Inflammatory Markers and RT-PCR in positive cases of COVID-19 - A Collaborative Study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/08/035815

Enrollment

Registered

2021-08-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B338- Other specified viral diseases

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients positive for COVID 19 confirmed by RT-PCR. 2) Patients with mild to moderate symptoms (NEWS 2 criteria).

Exclusion criteria

Exclusion criteria: Patients with 1) Diabetes Miletus. 2) Hepatic dysfunction 3) Renal dysfunction 4) Pulmonary dysfunction 5) Cardiovascular disease 6) Debilitating Neurological disorders. 7) Psychiatric illness. 8) Pregnant and Lactating. 9) Oxygen saturation less than 90%.

Design outcomes

Primary

Measure	Time frame
Changes in 1) COVID 19 Symptomatology. 2) RT-PCR 3) IL-6Timepoint: 2 weeks	—

Secondary

Measure	Time frame
Changes in 1) Hospital length stay. 2) Intensive care unit free days. 3) Oxygen saturation 4) Hospital Anxiety and depression Scale (HADS)Timepoint: 2 weeks	—

Countries

India

Contacts

Public ContactDr Kishore Kumar Ramakrishna

National Institute of Mental Health and Neurosciences

ayurkishore@gmail.com09845829174

Outcome results